268 related articles for article (PubMed ID: 3023426)
21. Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man.
Fahrenkrug J; Pedersen JH; Yamashita Y; Ottesen B; Hökfelt T; Lundberg JM
Regul Pept; 1987 Jul; 18(1):51-61. PubMed ID: 3306816
[TBL] [Abstract][Full Text] [Related]
22. Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide.
Kane MG; O'Dorisio TM; Krejs GJ
N Engl J Med; 1983 Dec; 309(24):1482-5. PubMed ID: 6316136
[TBL] [Abstract][Full Text] [Related]
23. [The VIP-secreting tumor as a differential diagnosis of protracted diarrhea in pediatrics].
Reindl T; Degenhardt P; Luck W; Riebel T; Sarioglu N; Henze G; Driever PH
Klin Padiatr; 2004; 216(5):264-9. PubMed ID: 15455292
[TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal polypeptide (VIP) as a mediator of the watery diarrhea syndrome.
Said SI
World J Surg; 1979 Sep; 3(5):559-63. PubMed ID: 229653
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects.
Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B
Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474
[TBL] [Abstract][Full Text] [Related]
26. Chronic diarrhea due to VIPoma in two children.
Socha J; Dobrzańska A; Rowecka K; Cichy W; Bierła J; Stodulski J; Woźniewicz B
J Pediatr Gastroenterol Nutr; 1984; 3(1):143-8. PubMed ID: 6319655
[TBL] [Abstract][Full Text] [Related]
27. Preoperative localization of a vasoactive intestinal peptide-secreting tumor by transhepatic portal venous sampling.
Parkman HP; Malet PF; Ogorek CP; Burke DR; Deveney CW
Am J Gastroenterol; 1988 May; 83(5):559-63. PubMed ID: 2834945
[TBL] [Abstract][Full Text] [Related]
28. [Vipomas].
Dupont C
Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
[TBL] [Abstract][Full Text] [Related]
29. VIPoma syndrome.
Krejs GJ
Am J Med; 1987 May; 82(5B):37-48. PubMed ID: 3035922
[TBL] [Abstract][Full Text] [Related]
30. Co-existence and co-secretion of the structurally related peptides VIP and PHI.
Fahrenkrug J
Scand J Clin Lab Invest Suppl; 1987; 186():43-50. PubMed ID: 3474771
[TBL] [Abstract][Full Text] [Related]
31. Corelease of PHI and VIP by vagal stimulation in the dog.
Yasui A; Naruse S; Yanaihara C; Ozaki T; Hoshino M; Mochizuki T; Daniel EE; Yanaihara N
Am J Physiol; 1987 Jul; 253(1 Pt 1):G13-9. PubMed ID: 2886054
[TBL] [Abstract][Full Text] [Related]
32. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
[TBL] [Abstract][Full Text] [Related]
33. Characterization and regional distribution of peptides derived from the vasoactive intestinal peptide precursor in the normal human brain.
Fahrenkrug J; Emson PC
J Neurochem; 1989 Oct; 53(4):1142-8. PubMed ID: 2769258
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
Wynick D; Williams SJ; Bloom SR
N Engl J Med; 1988 Sep; 319(10):605-7. PubMed ID: 2842676
[TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal polypeptide and peptide histidine methionine. Presence in human follicular fluid and effects on DNA synthesis and steroid secretion in cultured human granulosa/lutein cells.
Gräs S; Ovesen P; Andersen AN; Sørensen S; Fahrenkrug J; Ottesen B
Hum Reprod; 1994 Jun; 9(6):1053-7. PubMed ID: 7962375
[TBL] [Abstract][Full Text] [Related]
36. Verner-Morrison syndrome and vasoactive intestinal polypeptide (VIP).
Fahrenkrug J; Schaffalitzky de Muckadell OB
Scand J Gastroenterol Suppl; 1979; 53():57-60. PubMed ID: 225790
[TBL] [Abstract][Full Text] [Related]
37. In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-995).
Yasunami Y; Funakoshi A; Ryu S; Shinozaki H; Jimi A; Miyazaki K; Ikeda S
Surgery; 1994 Jun; 115(6):713-7. PubMed ID: 8197564
[TBL] [Abstract][Full Text] [Related]
38. 7B2, a possible marker for nonfunctioning pancreatic islet cell tumor.
Iguchi H; Yasuda D; Yamada Y; Funakoshi A; Wakasugi H; Bloom SR; Chretien M
Horm Metab Res; 1991 Oct; 23(10):486-9. PubMed ID: 1662184
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Neuroendocrine Tumor Secreting Vasoactive Intestinal Peptide and Dopamine With Pulmonary Emboli: A Case Report.
Nilubol N; Freedman EM; Quezado MM; Patel D; Kebebew E
J Clin Endocrinol Metab; 2016 Oct; 101(10):3564-3567. PubMed ID: 27583474
[TBL] [Abstract][Full Text] [Related]
40. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea.
Koch TR; Michener SR; Go VL
Gastroenterology; 1991 Jan; 100(1):99-106. PubMed ID: 1983854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
